BRIEF-Dimension Therapeutics to pay $2.9 mln to Regenxbio incase merger terminates

* Dimension Therapeutics – Upon termination of merger ,underspecified circumstances, co required to pay Regenxbiotermination fee $2.9 million- SEC filingSource text: (http://bit.ly/2vuWd1B)Further company coverage:
The post BRIEF-Dimension Therapeutics to pay $2.9 mln to Regenxbio incase merger terminates appeared first on RocketNews | Top News Stories From Around the Globe.